News

A plant-based fiber that feeds the good bacteria in your gut, XOS ensures that the probiotic strains in Bioma thrive and ...
SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding ...
Eligible members can now use their benefits for over-the-counter (OTC) medications and nutritious foods available at Publix stores. In addition, members may receive rewards on their &more cards for ...
The POSEIDON manuscript published in the American Journal of Gastroenterology in January 2025 concluded “the results from the literature indicate that the overall survival of patients with the alfa ...
BERKELEY, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Channel Medsystems, the medical device company that successfully launched the innovative Cerene ® technology for endometrial cryotherapy, announced ...
A link to the live and archived webcast may be accessed on Opus Genetics’ website under the Investors section: Events.
TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan (HOOPP) is proud to announce the launch of its 2030 Strategic Plan, a forward-thinking roadmap designed to reinforce ...
Männedorf, Switzerland, August 5, 2025 – The Tecan Group AG (SIX Swiss Exchange: TECN) will hold a conference call to discuss the financial results for the first half year 2025 on Tuesday, August 12th ...
IRB approval from Hadassah Medical Center follows Clearmind’s prior regulatory milestones, including U.S. Food and Drug Administration (FDA) clearance of its Investigational New Drug (IND) application ...
The webcast of the fireside chat will be accessible in the Investor section of the CervoMed website About CervoMed CervoMed is a clinical-stage company focused on developing treatments for ...
The Company’s pre-clinical data demonstrates CRB-913 is markedly more peripherally restricted than either monlunabant or rimonabant. CRB-913 has a brain to plasma ratio 50-times lower than rimonabant ...